uniQure (QURE) EBITDA Margin Growth (5y) (2021 - 2026)
uniQure (QURE) EBITDA Margin Growth (5y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
uniQure |
2.88 Bn |
2.88 Bn |
3.34 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
926,887.00 |
| Dec 31, 2025 |
-67,683.00 |
| Sep 30, 2025 |
29,475.00 |
| Jun 30, 2025 |
165,561.00 |
| Mar 31, 2025 |
2.91 Mn |
| Dec 31, 2024 |
-5,490.00 |
| Sep 30, 2024 |
88,891.00 |
| Jun 30, 2024 |
71,178.00 |
| Mar 31, 2024 |
142,479.00 |
| Dec 31, 2023 |
45,167.00 |
| Sep 30, 2023 |
-607,557.00 |
| Jun 30, 2023 |
-203,910.00 |
| Mar 31, 2023 |
-79,604.00 |
| Dec 31, 2022 |
102,589.00 |
| Sep 30, 2022 |
-460,128.00 |
| Jun 30, 2022 |
-1.31 Mn |
| Mar 31, 2022 |
-258,722.00 |
| Dec 31, 2021 |
8,321.00 |
| Sep 30, 2021 |
-233,202.00 |
| Jun 30, 2021 |
65,036.00 |
